Adding Apalutamide to Perioperative ADT Associated with Better Outcomes of Radical Prostatectomy for High-Risk Localised or Locally Advanced Prostate Cancer By Ogkologos - June 3, 2026 164 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the PROTEUS study Source RELATED ARTICLESMORE FROM AUTHOR ESMO Announces 2026 Society Award Recipients Honouring Excellence in Cancer Research, Care and Leadership Adjuvant Olaparib Continues to Improve Multiple Outcomes in Patients with Germline BRCA1/2-associated High-Risk HER2-negative EBC EMA Recommends Refusing the Marketing Authorisation for Copper (64Cu) Oxodotreotide MOST POPULAR 17 Old Fashioned Ways to Get Rid of Ants in Your... March 27, 2019 Combining existing drugs improves prostate cancer survival September 19, 2021 Molecular Analysis for Precision Oncology Congress 2024 London, UK, 16-18 October October 14, 2024 Germline Pathogenic Variants in CDH1, BRCA2, CHEK2, ATM, and PALB2 Associated... October 27, 2021 Load more HOT NEWS Adagrasib Shows Clinical Efficacy in Patients with Previously Treated KRASG12C-Mutated Advanced... Adjuvant Treatment with Nivolumab Plus Ipilimumab Combination Fails to Improve DFS... How Are Eligibility Criteria for Clinical Trials Changing to Help People... Stopping Treatment Is a Reasonable Strategy for Patients with Advanced NSCLC...
